BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16732326)

  • 1. Proteomics of acute myeloid leukaemia: Cytogenetic risk groups differ specifically in their proteome, interactome and post-translational protein modifications.
    Balkhi MY; Trivedi AK; Geletu M; Christopeit M; Bohlander SK; Behre HM; Behre G
    Oncogene; 2006 Nov; 25(53):7041-58. PubMed ID: 16732326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of childhood de novo acute myeloid leukemia and myelodysplastic syndrome/AML: correlation to molecular and cytogenetic analyses.
    Braoudaki M; Tzortzatou-Stathopoulou F; Anagnostopoulos AK; Papathanassiou C; Vougas K; Karamolegou K; Tsangaris GT
    Amino Acids; 2011 Mar; 40(3):943-51. PubMed ID: 20711619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and cytogenetics studies on acute myeloid leukemia with abnormality of chromosome 11].
    Lu Y; Xu W; Chen Z; Lou J; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):583-5. PubMed ID: 18841578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of cytogenetics in acute myeloid leukaemia.
    Mrózek K; Heinonen K; Bloomfield CD
    Best Pract Res Clin Haematol; 2001 Mar; 14(1):19-47. PubMed ID: 11355922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype.
    Breems DA; Van Putten WL; De Greef GE; Van Zelderen-Bhola SL; Gerssen-Schoorl KB; Mellink CH; Nieuwint A; Jotterand M; Hagemeijer A; Beverloo HB; Löwenberg B
    J Clin Oncol; 2008 Oct; 26(29):4791-7. PubMed ID: 18695255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for proteomic analysis of the sexually transmitted parasite Trichomonas vaginalis.
    De Jesus JB; Cuervo P; Junqueira M; Britto C; Silva-Filho FC; Sabóia-Vahia L; González LJ; Barbosa Domont G
    J Mass Spectrom; 2007 Nov; 42(11):1463-73. PubMed ID: 17960578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proteomics analysis of bone marrow cells of acute myeloid leukemia M2a and prognostic significance thereof].
    Tian S; Meng FY; Tang JM
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):538-41. PubMed ID: 17459203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific chromosomal aberrations in de novo acute myeloid leukemia: a comparative analysis of results with a report of three novel chromosomal rearrangements t(7;14)(q35;q13), t(8;18)(p11.2;q12), t(13;15) in Indian population.
    Ahmad F; Dalvi R; Das BR; Mandava S
    Cancer Detect Prev; 2008; 32(2):168-77. PubMed ID: 18639991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based age-specific incidences of cytogenetic subgroups of acute myeloid leukemia.
    Bacher U; Kern W; Schnittger S; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Nov; 90(11):1502-10. PubMed ID: 16266897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of technologically modified proteins in malt by combination of protein fractionation using convective interaction media and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Bobalova J; Chmelik J
    J Chromatogr A; 2007 Sep; 1163(1-2):80-5. PubMed ID: 17586515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes.
    Walters DK; Goss VL; Stoffregen EP; Gu TL; Lee K; Nardone J; McGreevey L; Heinrich MC; Deininger MW; Polakiewicz R; Druker BJ
    Leuk Res; 2006 Sep; 30(9):1097-104. PubMed ID: 16464493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
    Roe MR; Griffin TJ
    Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype.
    Patel JL; Pournazari P; Haggstrom SJ; Kosari F; Shabani-Rad MT; Natkunam Y; Mansoor A
    Histopathology; 2014 Jan; 64(2):226-33. PubMed ID: 24330148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK; Busch CM; Felix CA; Blair IA
    J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modifications of Desulfovibrio vulgaris Hildenborough sulfate reduction pathway proteins.
    Gaucher SP; Redding AM; Mukhopadhyay A; Keasling JD; Singh AK
    J Proteome Res; 2008 Jun; 7(6):2320-31. PubMed ID: 18416566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
    Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
    Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modifications.
    Hunzinger C; Schrattenholz A; Poznanović S; Schwall GP; Stegmann W
    J Chromatogr A; 2006 Aug; 1123(2):170-81. PubMed ID: 16822517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.